
Organization · Venture Capital
Three Leaf Ventures
Three Leaf Ventures is a Denver-based venture capital firm specializing in early-stage investments in healthcare technology. It is part of The Broe Group and focuses on enhancing patient access through innovative health solutions.
Overview
What Three Leaf Ventures does
What Three Leaf Ventures is
Three Leaf Ventures is a Denver-based venture capital firm specializing in early-stage investments in healthcare technology. It is part of The Broe Group and focuses on enhancing patient access through innovative health solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Three Leaf Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Three Leaf Ventures as a funder
Investment thesis
Three Leaf Ventures invests in innovators in the healthcare technology sector, focusing on enhancing patient access and control through emerging technologies.
Focus narrative
The firm emphasizes three key themes in its investment strategy: empowering proactive and educated healthcare consumers, leveraging advances in wireless and mobile communication technology, and transitioning from population-based medicine to individualized healthcare. Focus areas include health IT, mobile health apps, telemedicine, genomics, wearables, and consumer health platforms.
Value beyond capital
Three Leaf Ventures adds value to its portfolio companies by providing access to operational resources and capital from The Broe Group, along with strategic guidance in navigating the healthcare landscape.
Terms and economics
- Typical check
- $500,000–$3,000,000
Focus and fit
- Stages
- Seed · Series A
- Sectors
- Healthcare · Health Data · Telemedicine · Genomics · Digital Health
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
- Recorded notable exits
- Invitae
Portfolio context
Notable portfolio companies include: Beddr: Offers an FDA-registered sleep sensor called Sleep Tuner to improve sleep quality. Biolinq: Develops a biosensor patch for continuous monitoring of biomarkers, especially for diabetes. CirrusMD: A chat-first virtual care platform connecting users with board-certified physicians. Cohero Health: Improves respiratory care through connected devices and mobile applications. Genomenon: Provides a genomic search engine to enhance research and treatment decisions. Invitae: Integrates genetic testing into routine medical practice for better healthcare outcomes. Lemonaid Health: A direct-to-consumer remote healthcare provider offering affordable doctor visits.
Connected ecosystem
Continue from Three Leaf Ventures
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Three Leaf Ventures
Upseed classifies Three Leaf Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.